Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-10T05:12:17.616Z Has data issue: false hasContentIssue false
  • English
  • Français

Aluminum Neurotoxicity — Potential Role in the Pathogenesis of Neurofibrillary Tangle Formation

Published online by Cambridge University Press:  18 September 2015

Daniel P. Perl  and
William W. Pendlebury
Daniel P. Perl*
Affiliation:
Department of Pathology, University of Vermont, College of Medicine, Burlington, Vermont USA
William W. Pendlebury
Affiliation:
Department of Pathology, University of Vermont, College of Medicine, Burlington, Vermont USA
*
Neuropathology Division, Mount Sinai Medical Center, One Gustave Levy Place, New York, NY USA 10029
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Alzheimer's disease is a progressive neurodegenerative disease characterized neuropathologically by the development of large numbers of neurofibrillary tangles in certain neuronal populations of affected brains. This paper presents a review of the available evidence which suggests that aluminum is associated with Alzheimer's disease and specifically with the development of the neurofibrillary tangle. Aluminum salts innoculated into experimental animals produce neurofilamentous lesions which are similar, though not identical, to the neurofibrillary tangle of man. Although a few reports have suggested evidence of increased amounts of aluminum in the brains of Alzheimer's disease victims, such bulk analysis studies have been difficult to replicate. Using scanning electron microscopy with x-ray spectrometry, we have identified accumulations of aluminum in neurofibrillary tangle-bearing neurons of Alzheimer's disease. Similar accumulations have been identified in the neurofibrillary tangle-bearing neurons found in the brains of indigenous natives of Guam who suffer from parkinsonism with dementia and amyotrophic lateral sclerosis. This ongoing research still cannot ascribe a causal role of aluminum in the pathogenesis of neurofibrillary tangle formation; however, it does suggest that environmental factors may play an important part in the formation of this abnormality.

Type
Cellular Clues to Pathogenesis
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue S4 , November 1986 , pp. 441 - 445
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Alzheimer, A.Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Z Psychiartr 1907; 64: 146–148.Google Scholar
2.Corsellis, JNN.Aging and the dementias. In: Adams, JH, Corsellis, JAN, Duchen, LW, eds. Greenfield’s Neuropathology, 4th ed. New York: John Wiley, 1984: pp. 951–1025.Google Scholar
3.Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of demented old people. J Neurol Sci 1970; 2: 205–242.CrossRefGoogle Scholar
4.Tomlinson, BE, Blessed, G, Roth, M.Observations on the brains of nondemented old people. J Neurol Sci 1968; 7: 331–356.CrossRefGoogle ScholarPubMed
5.Dayan, AD.Quantitative histological studies on the aged human brain. 1. Senile plaques and neurofibrillary tangles in “normal” people. Acta Neuropath 1970; 16: 85–94.CrossRefGoogle Scholar
6.Klatzo, I, Wisniewski, H, Streicher, E.Experimental production of neurofibrillary degeneration. 1. Light microscopic observations. J Neuropath Exptl Neurol 1965; 24: 187–199.CrossRefGoogle Scholar
7.Terry, RD, Pena, C.Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis. J Neuropath Exptl Neurol 1965; 24: 200–210.CrossRefGoogle ScholarPubMed
8.Wisniewski, HM, Narkewica, O, Wisniewski, K.Topography and dynamics of neurofibrillary degeneration in aluminum encephalopathy. Acta Neuropathol 1967; 9: 172–133.CrossRefGoogle Scholar
9.Crapper, DR, Dalton, AJ.Alterations in short-term retention, conditioned avoidance response, acquisition and motivation following aluminum induced neurofibrillary degeneration. Physiol Behav 1973; 10: 925–933.CrossRefGoogle ScholarPubMed
10.Terry, RD.Electron microscopic studies of Alzheimer’s disease and of experimental neurofibrillary tangles. In: Bailey, OT, Smith, DE, eds. The Central Nervous System. Baltimore, Williams & Wilkins, 1968: 213–224.Google Scholar
11.Kidd, M.Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 1963; 197: 192–193.CrossRefGoogle ScholarPubMed
12.Wisniewski, HM, Narang, HK, Terry, RD.Neurofibrillary tangles of paired helical filaments. J Neurol Sci 1976; 27: 173–181.CrossRefGoogle ScholarPubMed
13.Selkoe, DJ, Ihara, Y, Salazar, FJ.Alzheimer’s disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 1982; 215: 1243–1245.CrossRefGoogle ScholarPubMed
14.Anderton, BH, Breinburg, D, Downes, MJ, et al. Monoclonal anti-bodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature 1982; 298: 84–86.CrossRefGoogle Scholar
15.Gambetti, P, Autulio-Gambetti, L, Perry, G, et al. Antibodies to neurofibrillary tangles of Alzheimer’s disease from human and animal neurofilament fractions. Lab Invest 1983; 49: 430–435.Google ScholarPubMed
16.Crapper, DR, Krishnan, SSDalton, AJ.Brain aluminum distribution in Alzheimer’s disease and especially neurofibrillary degeneration. Science 1973; 180: 511–513.CrossRefGoogle ScholarPubMed
17.Crapper, DR, Krishnan, SS, Quirrkat, S.Aluminum, neurofibrillary degeneration and Alzheimer’s disease. Brain 1976; 99: 67–80.CrossRefGoogle ScholarPubMed
18.Markesbury, WR, Ehmann, WD, Hossain, TIM, et al. Instrumental neutron activation analysis of brain aluminum in Alzheimer’s disease and aging. Ann Neurol 1981; 10: 511–516.CrossRefGoogle Scholar
19.McDermott, JR, Smith, AI, Igbal, K, et al. Brain aluminum in aging and Alzheimer disease. Neurology 1979; 29: 809–814.CrossRefGoogle ScholarPubMed
20.Trapp, GA, Miner, GD, Zimmerman, et al. Aluminum levels in brain in Alzheimer’s disease. Biol Psychiat 1978; 13: 709–718.Google ScholarPubMed
21.Perl, DP.Detection of aluminum in nervous system tissues by scanning electron microscopy. In: Wills, MR, Savory, J, eds. Aluminum Analysis in Biological Materials. Charlottesville, VA: Univ. Virginia Press, 1983: 34–44.Google Scholar
22.Perl, DP, Brody, AR.Alzheimer’s disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980; 208: 297–299.CrossRefGoogle ScholarPubMed
23.Perl, DP, Pendlebury, WW.Aluminum accumulation in neurofibril-lary tangle-bearing neurons of senile dementia, Alzheimer’s type — detection by intraneuronal X-ray spectrometry studies of unstained tissue sections. J Neuropath Exptl Neurol 1984; 43: 349.CrossRefGoogle Scholar
24.Wisniewski, K, Jervis, GA, Moretz, RC, et al. Alzheimer neurofibril-lary tangles in diseases other than senile and presenile dementia. Ann Neurol 1979; 5: 288–294.CrossRefGoogle ScholarPubMed
25.Kurland, LT, Mulder, DW.Epidemiologic investigations of amyo-trophic lateral sclerosis. Neurology 1954; 4: 355–378.CrossRefGoogle Scholar
26.Hirano, A, Kurland, LT, Krooth, RS, et al. Parkinsonism-dementia complex, an endemic disease on the island of Guam. — I. Clinical features. Brain 1961; 84: 642–661.CrossRefGoogle ScholarPubMed
27.Hirano, A, Malamud, N, Kurland, LT.Parkinsonism-dementia comples, an endemic disease on the island of Guam. II. Pathological features. Brain 1961; 84: 662–679.CrossRefGoogle Scholar
28.Malamud, N, Hirano, A, Kurland, LT.Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Special reference to the occurrence of neurofibrillary changes. Arch Neurol 1961; 29: 573–578.Google Scholar
29.Hirano, A, Arumugasamy, N, Zimmerman, HM.Amyotrophic lateral sclerosis: a comparison of Guam and classical cases. Arch Neurol 1967; 16: 357–363.CrossRefGoogle ScholarPubMed
30.Gajdusek, DC.Foci of motor neuron disease in high incidence in isolated populations of East Asia and the Western Pacific. In: Rowland, LP, ed. Advances in Neurology: Human Motor Neuron Diseases. New York: Raven Press, 1982; 36: 363–394.Google Scholar
31.Perl, DP, Gajdusek, DC, Garruto, RM, et al. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism dementia of Guam. Science 1982; 217: 1053–1054.CrossRefGoogle ScholarPubMed
32.Garruto, RM, Fukatsu, R, Yangihara, R, et al. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci (USA) 1984; 81: 1875–1879.CrossRefGoogle ScholarPubMed
33.Perl, DP, Munoz-Garcia, D, Good, PF, et al. Laser microprobe mass analyzer (LAMMA) — a new approach to the study of the association of aluminum and neurofibrillary tangle formation. In: Fisher, A, Hanin, I, eds. Alzheimer’s and Parkinsons’ Diseases. New York: Plenum, 1986; 241–248.CrossRefGoogle Scholar
34.Perl, DP, Munoz-Garcia, D, Good, PF, et al. Intracytoplasmic alumi-num accumulation in neurofibrillary tangle-bearing neurons: detection by laser microprobe mass analyzer (LAMMA). Ann Neurol 1985; 34: 264.Google Scholar
35.Heinen, HJ, Hillenkamp, F, Kaufmann, R, et al. LAMMA: A new laser microprobe mass analyzer for biomedicine and biological materials analysis. In: Frigerio, A, McCamish, M, eds. Recent Developments in Mass Spectometry in Biochemistry and Medicine. Amsterdam: Elsevier, 1980: 435–451.Google Scholar
36.Perl, DP, Munoz-Garcia, D, Good, PF, et al. Calculation of intracellu-lar aluminum concentration in neurofibrillary tangle (NFT) bearing and NFT-free neurons of ALS/Parkinsonism dementia (PD) of Guam using laser microprobe mass analysis (LAMMA). J Neuropath Exptl Neurol 1986; 45: 379.CrossRefGoogle Scholar
37.Underwood, EJ.Trace Elements in Human and Animal Nutrition. New York: Academic Press, 1977: p. 430.CrossRefGoogle Scholar
38.Karlick, SJ, Eichhorn, GL, Lewis, PN, et al. Interaction of alumi-num species with deoxyribonucleic acid. Biochemistry 1980; 19: 5991–5998.CrossRefGoogle Scholar
39.Lai, JCK, Blass, JP.Inhibition of brain glycolysis by aluminum. J Neurochem 1984; 42: 438–446.CrossRefGoogle ScholarPubMed
40.Wenk, GL, Stemmer, KL.Activity of the enzymes dopamine-beta-hydroxylase and phenylethanolamine-N-methyltransferase in discrete brain regions of the copper-zinc deficient rat following aluminum ingestion. Neurotoxicology 1982; 3: 93–99.Google ScholarPubMed
41.Marquis, JK, Lerrick, AJ.Noncompetitive inhibition by aluminum, scandium, and yttrium of acetylcholinesterase from “electro-phoruselectricus”. Biochem Pharmacology 1982; 31: 1437–1440.CrossRefGoogle Scholar
42.Kosik, KS, Bradley, WG, Good, PF, et al. Cholinergic function in lumbar aluminum myelopathy. J Neurpath Exptl Neurol 1983; 42: 365–375.CrossRefGoogle ScholarPubMed
43.Yates, CM, Simpson, J, Russell, D, et al. Cholinergic enzymes in neurofibrillary degeneration produced by aluminum. Brain Res 1980; 197: 269–274.CrossRefGoogle Scholar
44.Siegal, N, Coughlin, R, Haug, A.A thermodynamic and electron paramagnetic resonance study of structural changes in calmodulin induced by aluminum binding. Biochem Biophys Res Comm 1983; 115: 512–517.CrossRefGoogle Scholar
45.Siegel, N, Suhayda, C, Haug, A.Aluminum changes the conformation of calmodulin. Physiol Chem Physics 1982; 14: 165–169.Google ScholarPubMed
46.Heyman, A, Wilkinson, WE, Stafford, JA, et al. Alzheimer’s disease: a study of epidemiological aspects. Ann Neurol 1984; 15: 335–341.CrossRefGoogle ScholarPubMed
47.Yase, Y.The pathogenesis of amyotrophic lateral sclerosis. Lancet 1972; 2: 292–296.CrossRefGoogle ScholarPubMed
48.Reed, DM, Brody, JA.Amyotrophic lateral sclerosis and parkinson-ism-dementia on Guam, 1945–1972.1. Descriptive epidemiology. Amer J Epidemiol 1975; 101: 287–301.CrossRefGoogle ScholarPubMed
49.Garruto, RM, Yanagihara, R, Gajdusek, DC.Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 1985; 35: 193–198.CrossRefGoogle ScholarPubMed